PDF
File
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Extraordinary General Meeting in Pharmacolog i Uppsala AB, reg. no. 556723-6418, (the "Company"), took place today, Wednesday, November 15, 2023, at 10.00 am at Clarion Hotell Gillet in Uppsala.
All decisions were made in accordance with the Board's previously published proposal and with the required majority.
Decision on share capital reduction
It was resolved to reduce the Company's share capital by a maximum of SEK 11,449,591.081, however not lower than SEK 662,138.90, for allocation to non-restricted equity. After the reduction has been carried out, in accordance with the proposal, the Company's share capital will amount to SEK 662,503.42, divided into 66,250,342 shares, each share with a quota value of SEK 0.01. Provided that the required authorization is obtained, the reduction resolution is expected to be executed in January 2024.
Resolution on amendment of the articles of association
Due to the decision to reduce the share capital, it was decided that the limits of the articles of association for the share capital shall be amended in accordance with the below.
4 § Share capital
Current wording Proposed wording
The share capital is no less than SEK The share capital is not less than SEK
11,500,000 and no more than SEK 650,000 and not more than SEK
46,000,000. 2,600,000.